Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODIN: Darunavir/Ritonavir Once vs Twice Daily in Treatment-Experienced HIV-1
NCT00524368Phase 3Completed
- Sponsor
- Tibotec
- Start
- Oct 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Started Oct 2007; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00524368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524368.